SoluLinK, Inc. Awarded Phase I SBIR Contract to Develop a Multiplex Screen for the Rapid Detection of Breast Cancer
Published: Sep 15, 2011
The Small Business Innovation Research Program (SBIR) works to ensure that the nation’s small, high-tech, innovative businesses act as a significant part of the federal government’s research and development projects. In reviewing grant applications, the SBIR seeks unique research projects that are of high scientific caliber and are relevant to public health needs. SBIR Grant number: PH3 2010-1 NCI Topic 274
Solulink’s proprietary conjugation reagents and easy-to-use linking kits provide unique features and benefits used to link proteins, oligonucleotides, peptides, and antibodies to each other or to a wide range of surfaces including beads, chips, and slides. Solulink has developed several lines of products that incorporate its technology including streptavidin magnetic and agarose beads that have the highest binging capacity on the market, ChromaLink Biotin with a built in quantification feature, antibody labeling kits, oligo and peptide synthesis reagents. Solulink markets its products both directly and through distributors and licensing partners worldwide. Solulink is a privately held company located in San Diego, California. For more information, please visit www.solulink.com.
9853 Pacific Heights Blvd. Suite H,
San Diego, California 92121